Endocrinology | The FDA has approved a 10-mcg low-dose formulation of estradiol vaginaltablets for the treatment of atrophic vaginitis due to menopause. This approval makes the new formulation (Vagifem, Novo Nordisk) thelowest local estrogen therapy dose commercially available in the United State...
The estrogen potencies of three new oral contraceptive formulations--Brevicon, Modicon, and Lo/Ovral--were determined. Brevicon and Modicon were found to have estrogen potency equal to mestranol 50 mug and equal to or greater than Norinyl 1 + 50 and Ortho-Novuum 1 + 50. Lo/Ovral, which...
In a report by the Royal College of General Practitioners in England the results of a comparative study of 23000 pill users and an equal number of controls showed that the risk of thromboembolism was reduced by almost 28% by reducing the dosage of estrogen to 50 mcg or less. The increased...
Ok! For early postmenopausal women concerned about the effectiveness of low-dose estrogen therapy for alleviating menopause symptoms such as hot flashes, night sweats, insomnia, and irritability, data from the Kronos Early Estrogen Prevention Study (KEEPS) was used to compare the efficacy of two for...
These results suggest that there is an additive effect of low dose estrogen and calcium on bone resorption, but not on bone formation, in older women. Thus, the combination of low dose estrogen plus calcium is likely to be more effective in older women than either treatment alone. 展开 ...
dose estrogen therapy. The changes in community composition in response to hormonal therapy were rapid and typified by significant increases in the relative abundance ofLactobacillusspp. that were mirrored by a decreased relative abundance ofGardnerella. These changes were paralleled by a significant four...
Conclusion: Flaxseed + low-dose estrogen therapy provides the greatest protection against ovariectomy-induced bone loss at the lumbar vertebrae. Moreover, this study is the first to demonstrate that flaxseed, rich in alpha-linolenic acid, alters fatty acid composition in the ovariectomized rat ...
Estrogen and stroke: a case for low-dose estrogen SS Birge - 《Menopause-the Journal of the North American Menopause Society》 被引量: 0发表: 0年 Postmenopausal estrogen replacement therapy and risk of AD: a population-based study OBJECTIVE: To study the association between estrogen replacement ...
Effects of low dose estrogen replacement therapy on bone and lipid metabolism in Japanese postmenopausal womenAbstract Without Abstractdoi:10.1007/BF02500464T. NakamoraJ. T. ChenT. HoriuchiJ. InoueH. OrimoSpringer-VerlagOsteoporosis International
It is believed, but not proven, that the risk of breast cancer in women taking hormone replacement therapy is related to the dose of estrogen exposure over time. [0014] Despite substantial efforts made to date, there remains a need for improved HRT regimens that minimize estrogen exposure, ...